Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Uranium Stocks to Buy According to Hedge Funds

Page 1 of 3

With a surge in solar and wind powered energy, one would expect that demand for nuclear reactors to produce electricity. Still wary of everything nuclear following the Fukushima disaster, countries like Germany and Japan have stepped up efforts to reduce their dependence on nuclear-powered energy. This does not apply to China and India, whose appetite for nuclear reactors has not faded. With the price of Uranium far from the 2007 high and showing signs of a bottom, we have decided to take a look at the most popular mining stocks that are in the uranium business and see how the hedge funds have positioned themselves in this market.

The smart money sentiment is an important metric that can be used to assess the long-term profitability of a stock. While there are thousands of stocks trading daily on the market, taking a look at what hedge funds think about certain companies can narrow down the search significantly. At Insider Monkey, we track more than 700 hedge funds, whose 13F filings we analyze as part of our small-cap strategy. Our research has shown that imitating a portfolio that includes the 15 most popular small-cap stocks among hedge funds can outperform the market by as much as 95 basis points per month on average (see more details here).

The hedge fund sentiment towards Cameco Corporation (USA) (NYSE:CCJ) has slightly improved over the fourth quarter, with the number of funds with long positions increasing to 24 from 21. Cliff Asness’ AQR Capital Management is bullish on this stock, having increased its stake by 140% over the quarter to 2.85 million shares valued at a little over $35 million. Steven Cohen of Point72 Asset Management is also optimistic about the prospects of the company, having initiated a new position during the quarter and having amassed a total of 3.2 million shares. The management of Cameco Corporation (USA) (NYSE:CCJ) believes the price of uranium is set for a rebound and has stepped up efforts to increase production and to develop new mines in Canada and Australia once it becomes worthwhile. For the 2015 fourth quarter, Cameco Corporation (USA) (NYSE:CCJ) reported a loss of $7.5 million, having been hurt by higher impairment charges. When adjusted for one time costs, the company reported earnings of $0.38 per share on $730.6 million in revenues.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!